On November 17, 2017, Genentech filed suit against Pfizer in the District of Delaware, alleging that Pfizer’s biosimilar of Herceptin® infringes forty Genentech patents covering Herceptin® and its ...
FeDeriCa is an international, multi-center, two-arm, randomized, open-label, Phase III study evaluating the pharmacokinetics, efficacy and safety of SC injection of the FDC of Perjeta and Herceptin in ...
When you or a loved one has breast cancer, your doctor will figure out the best treatment options to offer you based on your particular tumor, your age, other conditions you have, and your wishes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback